A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer.

Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

Summary: New research reveals how a tiny chemical mark on RNA helps wire the brain during development. Scientists discovered ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

A strategy that analyzes the structural properties of RNA could help identify regions that are promising targets for antiviral drugs.

To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian ...

Because they rely on hosts for a majority of functions, viruses aren’t considered alive. But entities like this one ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...